CA2064705A1 - Methode de culture de hcv dans des cellules eucaryotiques - Google Patents

Methode de culture de hcv dans des cellules eucaryotiques

Info

Publication number
CA2064705A1
CA2064705A1 CA2064705A CA2064705A CA2064705A1 CA 2064705 A1 CA2064705 A1 CA 2064705A1 CA 2064705 A CA2064705 A CA 2064705A CA 2064705 A CA2064705 A CA 2064705A CA 2064705 A1 CA2064705 A1 CA 2064705A1
Authority
CA
Canada
Prior art keywords
methods
eukaryotic cells
culturing hcv
hcv
culturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2064705A
Other languages
English (en)
Other versions
CA2064705C (fr
Inventor
Amy J. Weiner
Kathelyn S. Steimer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23576300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2064705(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2064705A1 publication Critical patent/CA2064705A1/fr
Application granted granted Critical
Publication of CA2064705C publication Critical patent/CA2064705C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measurement Of Mechanical Vibrations Or Ultrasonic Waves (AREA)
  • Details Of Audible-Bandwidth Transducers (AREA)
  • Telephone Function (AREA)

Abstract

Cellules pouvant être utilisées afin de propager le virus de l'hépatite C en culture. L'invention concerne également des antigènes viraux produits à l'aide desdites cultures, ainsi que l'emploi desdits antigènes, par exemple, dans des diagnostics.
CA002064705A 1989-08-25 1990-08-22 Methode de culture de hcv dans des cellules eucaryotiques Expired - Lifetime CA2064705C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39866789A 1989-08-25 1989-08-25
US398,667 1989-08-25

Publications (2)

Publication Number Publication Date
CA2064705A1 true CA2064705A1 (fr) 1991-02-26
CA2064705C CA2064705C (fr) 1999-04-06

Family

ID=23576300

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002064705A Expired - Lifetime CA2064705C (fr) 1989-08-25 1990-08-22 Methode de culture de hcv dans des cellules eucaryotiques

Country Status (12)

Country Link
EP (1) EP0414475B1 (fr)
JP (3) JPH05502156A (fr)
AT (1) ATE161041T1 (fr)
AU (1) AU655156B2 (fr)
CA (1) CA2064705C (fr)
DE (1) DE69031791T2 (fr)
DK (1) DK0414475T3 (fr)
ES (1) ES2110411T3 (fr)
GR (1) GR3026114T3 (fr)
IE (1) IE903097A1 (fr)
PT (1) PT95093B (fr)
WO (1) WO1991002820A1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
BE1005485A5 (fr) 1989-12-18 1993-08-10 Wellcome Found Agent viral.
AU7672991A (en) * 1990-04-03 1991-10-30 Southwest Foundation For Biomedical Research Purified hcv and hcv proteins and peptides
WO1991015596A1 (fr) * 1990-04-04 1991-10-17 Protos, Inc. Inhibiteurs de la protease du virus de l'hepatite c
CA2079912C (fr) * 1990-04-06 2000-07-11 Gregory Reyes Epitopes du virus de l'hepatite c
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
EP0516270A3 (en) * 1991-04-10 1993-06-23 Immuno Japan Inc. Non-a, non-b hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides
US5428145A (en) * 1991-08-09 1995-06-27 Immuno Japan, Inc. Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
DE69232906T2 (de) * 1991-11-21 2004-01-15 Common Services Agency Edinbur Detektion des Hepatis-C Virus.
US5552310A (en) * 1992-06-12 1996-09-03 Hiroshi Yoshikura Replication of hepatitis C virus genome and identification of virus having high infectivity
AU6943994A (en) * 1993-05-04 1994-11-21 United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hepatitis c virus cell propagation and related methods
US5840565A (en) 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5851758A (en) * 1995-10-25 1998-12-22 Childrens Research Institute Cytopathic replication of hepatitis C virus in a new cell line
HUP9900388A3 (en) * 1996-01-29 2005-03-29 Virologic Inc South San Franci Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6242187B1 (en) 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
CA2269097C (fr) 1996-11-08 2007-01-09 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Synthese et purification de particules de type virus de l'hepatite c
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
AT407256B (de) * 1998-06-24 2001-02-26 Immuno Ag Hepatitis c-virus positive endometriale zelllinie
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
RU2286172C2 (ru) 2000-08-17 2006-10-27 Трипеп Аб Вакцины, содержащие рибавирин, и способы их использования
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
JP5175417B2 (ja) 2000-08-17 2013-04-03 トリペップ アクチ ボラゲット リバビリンを含むワクチンおよびその使用方法
CA2618429A1 (fr) 2005-05-25 2007-03-22 Tripep Ab Gene de fusion ns3/4a non structurel de l'hepatite c
US20090214593A1 (en) 2007-08-16 2009-08-27 Tripep Ab Immunogen platform
EP2185195A2 (fr) 2007-08-16 2010-05-19 Tripep Ab Plate-forme immunogène
GB201119011D0 (en) * 2011-11-03 2011-12-14 Queen Mary Innovation Ltd Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
EP0071640B1 (fr) * 1981-02-11 1986-06-04 Connaught Laboratories Incorporated Virus de l'hepatite non a et non b
AU613310B2 (en) * 1986-04-01 1991-08-01 Genelabs Incorporated Immortalized virus-specific tissue cells
NZ227011A (en) * 1987-11-18 1992-03-26 Chiron Corp Non-a, non-b-hepatitis (hepatitis c) antigens, proteins, nucleotide sequences, vaccines and kits

Also Published As

Publication number Publication date
AU6344990A (en) 1991-04-03
ES2110411T3 (es) 1998-02-16
EP0414475A1 (fr) 1991-02-27
AU655156B2 (en) 1994-12-08
JP2001314192A (ja) 2001-11-13
DE69031791D1 (de) 1998-01-22
PT95093A (pt) 1991-05-22
DE69031791T2 (de) 1998-04-02
EP0414475B1 (fr) 1997-12-10
ATE161041T1 (de) 1997-12-15
CA2064705C (fr) 1999-04-06
JP2004049235A (ja) 2004-02-19
WO1991002820A1 (fr) 1991-03-07
PT95093B (pt) 1997-11-28
JPH05502156A (ja) 1993-04-22
GR3026114T3 (en) 1998-05-29
IE903097A1 (en) 1991-02-27
DK0414475T3 (da) 1998-02-09

Similar Documents

Publication Publication Date Title
CA2064705A1 (fr) Methode de culture de hcv dans des cellules eucaryotiques
CA2039315A1 (fr) Cellule souche hematopoietique humaine
CA2045175A1 (fr) Production de proteines au moyen de la recombinaison homologue
AU4493993A (en) Culture vessel for cell cultures
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
CA2188165A1 (fr) Methode de multiplication et differenciation des cellules b et leur utilisation
DE69333855D1 (de) Aus einer mit einem Stamm von Multiple-Sklerosis-Virus infizierten Zellinie hergestelltes biologisches Virusmaterial
CA2073168A1 (fr) Biomasse utilisee pour la production de virus et d'antigenes viraux
JPS5639779A (en) Cell culturing method of hematisis a type virus
AU2002361797A1 (en) Cell lines with latent immunodeficiency virus and methods of use thereof
ZA917561B (en) Media for culture of mammalian cells
AU8217387A (en) Process and device for the cultivation of immobilized or adherent mammalian cells, and the use thereof in the preparation of proteins
EP0204522A3 (fr) Série d'anticorps monoclonaux pour la caractérisation de la compatibilité histologique
PT80174A (en) Process for the preparation of n1-methyl-10alpha-methoxylumilysergol and esters thereof and intermediates for their preparation
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
AU5967380A (en) Eukaryotic cell culture
AU6295390A (en) Cell culture methods for producing activated protein c
CA2222718A1 (fr) Cellules 293 presentant une faculte de fixation amelioree
AU6262786A (en) Growing aids virus in cell lines lacking human class ii histocompatability antigens
JPS5534017A (en) Preparation of itaconic acid
JPS5571491A (en) Preparation of proline acylase
DK204586D0 (da) Hybridceller, der producerer et karakteristisk antigen for hepatitis b-virus, opnaaet ud fra hepatocytter og celler, der er tilvejebragt fra aber, fremgangsmaade til opnaaelse af hybridcellerne og anvendelse af disse til produktion af antigenet
CA2133345A1 (fr) Methode pour limiter la survie de microorganismes obtenus par voie genetique dans leur milieu
EP0191607A3 (fr) Culture de champignons
CA2058785A1 (fr) Methode pour l'obtention de proteines avec des derives fviii et ou a activite fviii

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry